World's Best Scientists 2026 revealed!
Nicholas M. Valiante

Nicholas M. Valiante

D-Index & Metrics

Biology and Biochemistry

D-Index
46
Citations
16574
World Ranking
18820
National Ranking
362

Nicholas M. Valiante publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Nicholas M. Valiante sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 101 publications — 5th percentile

5% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Nicholas M. Valiante D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Nicholas M. Valiante sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 46 D-Index — 4th percentile

4% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Nicholas M. Valiante is affiliated with Novartis in Switzerland, contributing to the fields of biochemistry, genetics, and molecular biology. Their research spans multiple subfields including molecular biology, computational theory and mathematics, materials chemistry, and epidemiology.

The scientist's main topics of work include:

  • Computational Drug Discovery Methods
  • Machine Learning in Materials Science
  • Chemical Synthesis and Analysis
  • Bacillus and Francisella bacterial research
  • Influenza Virus Research Studies
  • Hepatitis B Virus Studies
  • Protein Structure and Dynamics

Frequent collaboration is observed with several coauthors, including:

  • Paul A. Bertin
  • Jarrid Rector-Brooks
  • Deepak Sharma
  • Thomas Gaudelet
  • Andrew Anighoro

Valiante has published in venues such as:

  • Regular and Young Investigator Award Abstracts
  • Cell Reports Methods
  • Frontiers in Microbiology
  • arXiv (Cornell University)

Recent papers authored or coauthored by Valiante include:

  • RECOVER identifies synergistic drug combinations in vitro through sequential model optimization, 2023, Cell Reports Methods
  • RECOVER: sequential model optimization platform for combination drug repurposing identifies novel synergistic compounds in vitro, 2022, arXiv (Cornell University)
  • A Novel Toll-Like Receptor 2 Agonist Protects Mice in a Prophylactic Treatment Model Against Challenge With Bacillus anthracis, 2022, Frontiers in Microbiology
  • 822 Computational modeling to overcome MHC diversity and drive potent and diverse neoantigen and viral antigen specific killer T cell responses, 2025, Regular and Young Investigator Award Abstracts
  • 562 A phase Ia study to assess the safety, tolerability and immunogenicity of a personalized cancer vaccine (InnoPCV/INV002) in patients with advanced solid tumors, 2025, Regular and Young Investigator Award Abstracts

Best Publications

  • Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells.

    A. D'andrea;M. Aste-Amezaga;N. M. Valiante;Xiaojing Ma

  • Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells.

    A D'Andrea;M Rengaraju;N M Valiante;J Chehimi

  • Human Diversity in Killer Cell Inhibitory Receptor Genes

    Markus Uhrberg;Nicholas M Valiante;Benny P Shum;Heather G Shilling

  • Functionally and Structurally Distinct NK Cell Receptor Repertoires in the Peripheral Blood of Two Human Donors

    Nicholas M Valiante;Markus Uhrberg;Heather G Shilling;Kristin Lienert-Weidenbach

  • Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells.

    Diego Piccioli;Silverio Sbrana;Emiliano Melandri;Nicholas M. Valiante

  • mTOR inhibition improves immune function in the elderly

    Joan B. Mannick;Giuseppe Del Giudice;Maria Lattanzi;Nicholas M. Valiante

  • Targeting the innate immune response with improved vaccine adjuvants

    Achal Pashine;Nicholas M Valiante;Jeffrey B Ulmer

  • Nonviral delivery of self-amplifying RNA vaccines

    Andrew J. Geall;Ayush Verma;Gillis R. Otten;Christine A. Shaw

  • Interleukin 10 (IL-10) Inhibits Human Lymphocyte Interferon 3,-Production by Suppressing Natural Killer Cell Stimulatory Factor/IL-12 Synthesis in Accessory Cells By Annalisa D'Andrea, Miguel Aste-Amezaga,

    Nicholas M. Valiante;Xiaojing Ma;Marek Kubin;Giorgio Trinchieri

  • Inhibition of Natural Killer Cells through Engagement of CD81 by the Major Hepatitis C Virus Envelope Protein

    Stefania Crotta;Annalisa Stilla;Andreas Wack;Annalisa D'Andrea

  • Recent advances in the discovery and delivery of vaccine adjuvants.

    Derek T. O'Hagan;Nicholas M. Valiante

  • New adjuvants for human vaccines.

    M Lamine Mbow;Ennio De Gregorio;Nicholas M Valiante;Rino Rappuoli

  • A Cationic Nanoemulsion for the Delivery of Next-generation RNA Vaccines

    Luis A Brito;Michelle Chan;Christine A Shaw;Armin Hekele

  • Rapid Evolution of NK Cell Receptor Systems Demonstrated by Comparison of Chimpanzees and Humans

    Salim I Khakoo;Raja Rajalingam;Benny P Shum;Kristin Weidenbach

  • Identification of a novel signal transduction surface molecule on human cytotoxic lymphocytes.

    Nicholas M. Valiante;Giorgio Trinchieri

  • NKp46 and NKG2D Recognition of Infected Dendritic Cells Is Necessary for NK Cell Activation in the Human Response to Influenza Infection

    Monia Draghi;Achal Pashine;Bharati Sanjanwala;Ketevan Gendzekhadze

  • Natural killer cell stimulatory factor (NKSF) or interleukin-12 is a key regulator of immune response and inflammation.

    Giorgio Trinchieri;Maria Wysocka;Annalisa D'Andrea;Manthrasalam Rengaraju

  • Conserved and variable residues within the Bw4 motif of HLA-B make separable contributions to recognition by the NKB1 killer cell-inhibitory receptor.

    J E Gumperz;L D Barber;N M Valiante;L Percival

  • Heterogeneous phenotypes of expression of the NKB1 natural killer cell class I receptor among individuals of different human histocompatibility leukocyte antigens types appear genetically regulated, but not linked to major histocompatibililty complex haplotype.

    J E Gumperz;N M Valiante;P Parham;L L Lanier

  • Dynamics of intra‐hepatic lymphocytes in chronic hepatitis C: enrichment for Vα24+ T cells and rapid elimination of effector cells by apoptosis

    Sandra Nuti;Domenico Rosa;Nicholas M. Valiante;Giulietta Saletti

Frequent Co-Authors

Peter Parham
Peter Parham Stanford University
Manmohan Singh
Manmohan Singh Beam Therapeutics
Derek O'hagan
Derek O'hagan GlaxoSmithKline (United Kingdom)
Lewis L. Lanier
Lewis L. Lanier University of California, San Francisco
Ennio De Gregorio
Ennio De Gregorio Novartis (Switzerland)
Giorgio Trinchieri
Giorgio Trinchieri National Institutes of Health
Rino Rappuoli
Rino Rappuoli Imperial College London
Jeffrey B. Ulmer
Jeffrey B. Ulmer Novartis (Switzerland)
John J. Donnelly
John J. Donnelly Novartis (United States)
Andreas Wack
Andreas Wack The Francis Crick Institute

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring further studies in Biology and Biochemistry opens up diverse and rewarding career paths. Many students now opt for flexible learning through online degree programs related to healthcare, research, and wellness.

For those interested in healthcare leadership, a doctorate in healthcare administration online can pave the way to executive roles in hospitals and public health organizations. If your passion lies in medication and patient care, consider online pharm d programs that prepare you for a professional pharmacy career.

If your focus is on physical wellness and performance, a sports science degree online provides the knowledge to work in athletic training, coaching, or wellness consulting. Alternatively, kinesiology online programs equip students to pursue careers in rehabilitation, occupational therapy, or fitness instruction.

Online pathways offer flexible options for professionals and students to advance in these dynamic, growing fields—aligning with the evolving needs of healthcare and science industries.

Best Scientists Citing Nicholas M. Valiante

Trending Scientists

Recently Published Articles